Scientists Urge Regulators to Rethink Kratom Crackdown

Kratom, a traditional Southeast Asian leaf remedy, is emerging as a controversial self-treatment for pain and opioid dependence in the West. While US regulators have branded its key alkaloids “narcotic-like opioids,” the scientific evidence suggests a more nuanced picture. Research indicates kratom’s main compounds act on mu-opioid receptors but via mechanisms that appear to avoid the dangerous respiratory suppression seen with classical opioids. Most poison control reports involve minor or moderate symptoms such as nausea, constipation and drowsiness. The authors argue that equating kratom with far more lethal opioids could push some users back to heroin or prescription painkillers. Instead, they call for evidence-based regulation focused on product quality and marketing, while maintaining legal access for therapeutic users. Read the original article, “The therapeutic potential of kratom,” in Addiction at Wiley Online Library.